'''CURE NEWS: 12/5/2019

Molecule Triggers Self-Destruction of Pancreatic Cancer Cells, Scientists Discover

https://www.naturalblaze.com/2019/12/molecule-triggers-self-destruction-of-pancreatic-cancer-cells-scientists-discover.html

http://web.archive.org/web/20191205232246/https://www.naturalblaze.com/2019/12/molecule-triggers-self-destruction-of-pancreatic-cancer-cells-scientists-discover.html

The researchers inserted xenografts—in this case, human pancreatic cancer cells— into mice whose immune systems were suppressed so they wouldn’t reject the foreign cells, and saw the cells multiply below the skin.

They then injected the molecule PJ34 into the bloodstream of the mice to see if it would affect the tumor. After 14 days there was a substantial reduction of 80% to 90% of the cancer cells. In one mouse, the tumor completely disappeared.

“This molecule causes an anomaly during the duplication of human cancer cells, provoking their rapid cell death,” said Tel Aviv University’s Cohen-Armon in a statement. “Thus, cell multiplication itself resulted in cell death in the treated cancer cells.”

Cohen-Armon added that “no adverse effects were observed and there were no changes in the weight gain of the mice, nor in their behavior.”

“The effect of a daily treatment with PJ34 provided results with higher statistical significance than those obtained by the 3 times a week treatment with PJ34. However, both treatments caused a similar massive reduction of human proteins in the tumors, 30 days after the treatment with PJ34 has been terminated,” the study reads.

While further research needs to be done in order to calculate the appropriate doses that would have to be administered to human patients in the future, this study is encouraging news. Cohen-Armon added that the team hopes to start testing the effect of the molecule on larger animals, and eventually on humans, which could take around two years, depending on funding.

Hopefully, we can make use of these huge breakthroughs in cancer research really soon.

FUCKERY NEWS: 12/4/2019

Study Finds Key Brain Region Smaller in Birth Control Pill Users

http://press.rsna.org/timssnet/media/pressreleases/14_pr_target.cfm?ID=2136

http://web.archive.org/web/20191205232810/http://press.rsna.org/timssnet/media/pressreleases/14_pr_target.cfm?ID=2136

• The first study to examine the effects of oral contraceptives on the structure of the living human hypothalamus found that women taking birth control pills had significantly smaller hypothalamus volume.

• The hypothalamus helps regulate essential bodily functions including body temperature, mood, appetite, sex drive, sleep cycles and heart rate.

• Smaller hypothalamic volume was also associated with greater anger and showed a strong correlation with depression.

In his study, Dr. Lipton and colleagues recruited a group of 50 healthy women, including 21 women who were taking oral contraceptives. All 50 women underwent brain MRI, and a validated approach was used to measure hypothalamic volume.

"We found a dramatic difference in the size of the brain structures between women who were taking oral contraceptives and those who were not," Dr. Lipton said. "This initial study shows a strong association and should motivate further investigation into the effects of oral contraceptives on brain structure and their potential impact on brain function."

Other findings from the study, which Dr. Lipton described as "preliminary," were that smaller hypothalamic volume was also associated with greater anger and showed a strong correlation with depressive symptoms. However, the study found no significant correlation between hypothalamic volume and cognitive performance.

Co-authors are Ke Xun Chen, M.D., Sandie Worley, B.S., Henry J. Foster, B.S., David Edasery, M.D., Shima Roknsharifi, M.D., and Chloe Ifrah, B.A. The study was funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke and by The Dana Foundation.